FDA Establishing ‘Golden’ Manufacturing Facility Records
This article was originally published in The Gold Sheet
Executive Summary
“Golden” records should give FDA greater certainty about which pharmaceutical manufacturing facilities it regulates – and where they are.
You may also be interested in...
US FDA Drops Plan To Simplify Pharmaceutical Plant Reporting
Industry complained draft guidance would have made manufacturing establishment information harder to report, not easier.
‘Shadow’ Factory Challenges Continue For US FDA
Agency wants more information about API suppliers as it winds up case against KV Tech for hidden use of Dr. Reddy’s plant and seeks to find disappearing manufacturer of contaminated OTC eye drops.
US FDA, USP Raise Questions About Valisure’s Assertions Of Benzoyl Peroxide’s Benzene Risks
The US drug regulatory authority and standard-setting organization are evaluating the drug-screening venture’s findings regarding stability and potential carcinogenic risks associated with the widely used acne treatment, which includes Rx formulations.